Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
2500 participants
OBSERVATIONAL
2023-02-15
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions are:
* assessment of long-term prognosis of AHF and its determinants
* determination of the optimal AHF treatment methods
* assessment of indications for invasive coronary arteries diagnostics and revascularization and their long-term effects
* analysis of the particular HF subtypes (HFimpEF, HFpEF, HFsnEF, HFrEF, HFmrEF)
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The HF-POL Study - Multicenter Study of Polish Patients With HF and LVEF >40%
NCT06030661
Impact of Hear Failure on Lungs in Patients With Heart Failure
NCT05191459
Registry of Patients Referred for Heart Transplantation
NCT00690157
Observational Study on the Patient's Ability to Use a Digital Platform in Heart Failure
NCT06869408
Predictors of an Unfavorable Outcome in Patients With Heart Failure
NCT04753814
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
As part of the LECRA-HF registry, a comprehensive analysis of the clinical characteristics of patients is planned, taking into account their medical history, anthropometric measurements, results of electrocardiographic, imaging and laboratory tests, as well as the treatment used during the index hospitalization and after discharge. Their long-term prognosis will also be analyzed. LECRA-HF is a continuous registry, updated annually until 2026.
The data collected in the LECRA-HF will be used to distinguish and describe relatively new subtypes of HF (HFimpEF, HFsnEF) as well as to properly characterize that difficult and very diverse population with a serious long-term prognosis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
LECRA-HF patients
The study population consists of hospitalized patients with acute heart failure who are over 18 years of age, both women and men. Patients will be initially categorized into one of three groups based on the current European Society of Cardiology (ESC) heart failure guidelines based on left ventricular ejection fraction (LVEF) values: patients with reduced (LVEF ≤40%), mildly reduced (LVEF 41-49%) and preserved (LVEF ≥50%) ejection fraction.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* \> 18 years of age
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jagiellonian University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Konrad Stępień
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jadwiga Nessler, Prof.
Role: STUDY_CHAIR
Department of Coronary Disease and Heart Failure, John Paul II Hospital in Krakow
Konrad Stępień, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Coronary Disease and Heart Failure, John Paul II Hospital in Krakow
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Coronary Disease and Heart Failure, John Paul II Hospital in Krakow, Jagiellonian University Medical College
Krakow, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1072.6120.349.2022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.